665 related articles for article (PubMed ID: 28412169)
1. Engineered Exosomes as Vehicles for Biologically Active Proteins.
Sterzenbach U; Putz U; Low LH; Silke J; Tan SS; Howitt J
Mol Ther; 2017 Jun; 25(6):1269-1278. PubMed ID: 28412169
[TBL] [Abstract][Full Text] [Related]
2. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
3. Pseudotyping exosomes for enhanced protein delivery in mammalian cells.
Meyer C; Losacco J; Stickney Z; Li L; Marriott G; Lu B
Int J Nanomedicine; 2017; 12():3153-3170. PubMed ID: 28458537
[TBL] [Abstract][Full Text] [Related]
4. Nedd4 family-interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4 family proteins.
Putz U; Howitt J; Lackovic J; Foot N; Kumar S; Silke J; Tan SS
J Biol Chem; 2008 Nov; 283(47):32621-7. PubMed ID: 18819914
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles.
Do MA; Levy D; Brown A; Marriott G; Lu B
Sci Rep; 2019 Nov; 9(1):17274. PubMed ID: 31754156
[TBL] [Abstract][Full Text] [Related]
6. Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture.
Luhtala N; Hunter T
PLoS One; 2018; 13(9):e0203290. PubMed ID: 30192821
[TBL] [Abstract][Full Text] [Related]
7. Development of exosome surface display technology in living human cells.
Stickney Z; Losacco J; McDevitt S; Zhang Z; Lu B
Biochem Biophys Res Commun; 2016 Mar; 472(1):53-9. PubMed ID: 26902116
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of exosome-targeting peptides via engineered glycosylation.
Hung ME; Leonard JN
J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
Xitong D; Xiaorong Z
Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
[TBL] [Abstract][Full Text] [Related]
11. NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation.
Cheng Y; Lu X; Li F; Chen Z; Zhang Y; Han Q; Zeng Q; Wu T; Li Z; Lu S; Williams C; Xia W
Protein Cell; 2023 Mar; 14(2):123-136. PubMed ID: 36929005
[TBL] [Abstract][Full Text] [Related]
12. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems.
Mittal R; Bencie N; Langlie J; Mittal J; Eshraghi AA
J Cell Physiol; 2021 Dec; 236(12):8035-8049. PubMed ID: 34224589
[TBL] [Abstract][Full Text] [Related]
13. Differential fates of biomolecules delivered to target cells via extracellular vesicles.
Kanada M; Bachmann MH; Hardy JW; Frimannson DO; Bronsart L; Wang A; Sylvester MD; Schmidt TL; Kaspar RL; Butte MJ; Matin AC; Contag CH
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1433-42. PubMed ID: 25713383
[TBL] [Abstract][Full Text] [Related]
14. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells.
Putz U; Howitt J; Doan A; Goh CP; Low LH; Silke J; Tan SS
Sci Signal; 2012 Sep; 5(243):ra70. PubMed ID: 23012657
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
17. Exosomes in Parkinson's Disease: Current Perspectives and Future Challenges.
Yuan L; Li JY
ACS Chem Neurosci; 2019 Feb; 10(2):964-972. PubMed ID: 30664350
[TBL] [Abstract][Full Text] [Related]
18. Exosome as a Delivery Vehicle for Cancer Therapy.
Moon B; Chang S
Cells; 2022 Jan; 11(3):. PubMed ID: 35159126
[TBL] [Abstract][Full Text] [Related]
19. Transfer of the Cystic Fibrosis Transmembrane Conductance Regulator to Human Cystic Fibrosis Cells Mediated by Extracellular Vesicles.
Vituret C; Gallay K; Confort MP; Ftaich N; Matei CI; Archer F; Ronfort C; Mornex JF; Chanson M; Di Pietro A; Boulanger P; Hong SS
Hum Gene Ther; 2016 Feb; 27(2):166-83. PubMed ID: 26886833
[TBL] [Abstract][Full Text] [Related]
20. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
